3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate ...

Q1 2026 earnings call recap: margins up, cost cuts, new PlusHLTH launches, CMS BEI update & cash flow outlook—read now.

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

Anthropic PBC has had a busy start to the week, launching a new tool called Claude for Life Sciences to help with scientific research, and expanding the availability of its Claude Code agentic coding ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 5:20 PM EDTCompany ParticipantsJohanna Mercier - ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

More than 140,000 fake citations across four research repositories were identified in papers and preprints published in 2025 ...

Graduates from Quinnipiac’s College of Arts & Sciences and School of Communications celebrated Commencement on Saturday at ...